Vesigen Therapeutics

About:

Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.

Website: https://www.vesigentx.com/

Twitter/X: vesigen_tx

Top Investors: Alexandria Venture Investments, Leaps by Bayer, Morningside Venture Investments, FARA, Linden Lake Ventures

Description:

Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets.

Total Funding Amount:

$28.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Quan Lu, Robert Millman

Number of Employees:

1-10

Last Funding Date:

2023-03-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai